Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 16.4B | 14.1B | 13.5B | 12.5B |
Cost of revenue | 11.4B | 9.6B | 9.4B | 8.7B |
Gross profit | 5.0B | 4.4B | 4.1B | 3.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.1B | 2.7B | 2.7B | 2.4B |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 1.7B | 1.4B | 1.3B |
Non operating interest income | ||||
Income | 59M | 63M | 66M | 69M |
Expense | 17M | 20M | 20M | 19M |
Other income expense | — | — | — | — |
Pretax income | 1.9B | 1.7B | 1.5B | 1.4B |
Tax provision | 491M | 439M | 369M | 320M |
Net income | 1.4B | 1.3B | 1.1B | 1.1B |
Basic EPS | 1.2 | 1.1 | 1.0 | 0.9 |
Diluted EPS | 1.2 | 1.1 | 1.0 | 0.9 |
Basic average shares | 1.1B | 1.1B | 1.1B | 1.1B |
Diluted average shares | 1.1B | 1.1B | 1.1B | 1.1B |
EBITDA | 2.2B | 2.0B | 1.8B | 1.7B |
Net income from continuing op. | 1.4B | 1.3B | 1.1B | 1.1B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |